Free Trial

Johnson & Johnson (JNJ) Competitors

Johnson & Johnson logo
$174.46 +0.04 (+0.02%)
As of 12:01 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

JNJ vs. ISRG, MRNA, NVAX, ABBV, BRK.B, LLY, MRK, PFE, PG, and XOM

Should you be buying Johnson & Johnson stock or one of its competitors? The main competitors of Johnson & Johnson include Intuitive Surgical (ISRG), Moderna (MRNA), Novavax (NVAX), AbbVie (ABBV), Berkshire Hathaway (BRK.B), Eli Lilly and Company (LLY), Merck & Co., Inc. (MRK), Pfizer (PFE), Procter & Gamble (PG), and Exxon Mobil (XOM).

Johnson & Johnson vs. Its Competitors

Johnson & Johnson (NYSE:JNJ) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability, media sentiment and earnings.

Johnson & Johnson has higher revenue and earnings than Intuitive Surgical. Johnson & Johnson is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Johnson & Johnson$88.82B4.73$14.07B$9.3518.66
Intuitive Surgical$8.35B20.41$2.32B$7.1766.32

Johnson & Johnson has a beta of 0.41, suggesting that its share price is 59% less volatile than the S&P 500. Comparatively, Intuitive Surgical has a beta of 1.59, suggesting that its share price is 59% more volatile than the S&P 500.

69.6% of Johnson & Johnson shares are held by institutional investors. Comparatively, 83.6% of Intuitive Surgical shares are held by institutional investors. 0.2% of Johnson & Johnson shares are held by company insiders. Comparatively, 0.7% of Intuitive Surgical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Intuitive Surgical has a net margin of 28.51% compared to Johnson & Johnson's net margin of 25.00%. Johnson & Johnson's return on equity of 32.49% beat Intuitive Surgical's return on equity.

Company Net Margins Return on Equity Return on Assets
Johnson & Johnson25.00% 32.49% 13.00%
Intuitive Surgical 28.51%14.56%12.93%

Johnson & Johnson presently has a consensus target price of $174.50, indicating a potential upside of 0.02%. Intuitive Surgical has a consensus target price of $595.95, indicating a potential upside of 25.34%. Given Intuitive Surgical's higher probable upside, analysts clearly believe Intuitive Surgical is more favorable than Johnson & Johnson.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Johnson & Johnson
0 Sell rating(s)
9 Hold rating(s)
9 Buy rating(s)
2 Strong Buy rating(s)
2.65
Intuitive Surgical
1 Sell rating(s)
5 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.63

In the previous week, Johnson & Johnson had 35 more articles in the media than Intuitive Surgical. MarketBeat recorded 90 mentions for Johnson & Johnson and 55 mentions for Intuitive Surgical. Johnson & Johnson's average media sentiment score of 1.57 beat Intuitive Surgical's score of 1.51 indicating that Johnson & Johnson is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Johnson & Johnson
84 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Intuitive Surgical
50 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Summary

Johnson & Johnson beats Intuitive Surgical on 9 of the 17 factors compared between the two stocks.

Get Johnson & Johnson News Delivered to You Automatically

Sign up to receive the latest news and ratings for JNJ and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding JNJ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

JNJ vs. The Competition

MetricJohnson & JohnsonLarge Cap Pharma IndustryMedical SectorNYSE Exchange
Market Cap$420.20B$240.23B$5.58B$20.89B
Dividend Yield3.01%2.98%4.62%3.61%
P/E Ratio18.6629.5730.2628.20
Price / Sales4.734.68446.9779.29
Price / Cash13.1712.5337.7523.46
Price / Book5.357.108.405.35
Net Income$14.07B$8.49B$3.25B$994.60M
7 Day Performance1.78%3.88%3.50%2.01%
1 Month Performance11.18%-2.71%3.86%0.91%
1 Year Performance10.10%-9.22%35.40%15.19%

Johnson & Johnson Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
JNJ
Johnson & Johnson
4.7233 of 5 stars
$174.46
+0.0%
$174.50
+0.0%
+10.0%$420.20B$88.82B18.66138,100Positive News
ISRG
Intuitive Surgical
4.8051 of 5 stars
$471.09
+0.2%
$595.95
+26.5%
+2.8%$168.86B$8.35B65.7015,638Positive News
MRNA
Moderna
4.4638 of 5 stars
$25.64
-1.9%
$43.59
+70.0%
-67.6%$9.94B$3.24B-3.395,800
NVAX
Novavax
4.7495 of 5 stars
$7.94
-5.2%
$15.86
+99.8%
-27.2%$1.29B$1.08B3.471,990Analyst Revision
ABBV
AbbVie
4.7457 of 5 stars
$197.83
-0.1%
$214.43
+8.4%
+5.3%$349.02B$56.33B94.0855,000Trending News
Analyst Forecast
BRK.B
Berkshire Hathaway
1.8346 of 5 stars
$464.62
-0.2%
$575.00
+23.8%
+10.4%$1.00T$371.43B15.92392,400
LLY
Eli Lilly and Company
4.9993 of 5 stars
$643.44
+2.8%
$977.65
+51.9%
-27.3%$609.38B$53.26B42.0247,000Trending News
Earnings Report
Analyst Forecast
Insider Trade
High Trading Volume
MRK
Merck & Co., Inc.
4.9956 of 5 stars
$79.97
-0.9%
$107.44
+34.4%
-27.7%$199.62B$64.17B12.3175,000Positive News
PFE
Pfizer
4.9912 of 5 stars
$24.68
+0.4%
$28.12
+14.0%
-12.9%$140.23B$63.83B13.1281,000Trending News
PG
Procter & Gamble
4.7257 of 5 stars
$155.20
+1.1%
$175.88
+13.3%
-7.1%$363.54B$84.28B23.84109,000Positive News
Analyst Revision
XOM
Exxon Mobil
4.8347 of 5 stars
$105.91
-0.8%
$125.26
+18.3%
-8.8%$451.40B$349.59B15.0461,000Positive News

Related Companies and Tools


This page (NYSE:JNJ) was last updated on 8/14/2025 by MarketBeat.com Staff
From Our Partners